+1 (704) 266-3234

Global Pharmaceutical Intermediates Market Growth 2020-2025

Published on: Jul 2020 | From USD $3660 | Published By: LP INFORMATION INC | Number Of Pages: 165

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of Pharmaceutical Intermediates will have significant change from previous year. By the most conservative estimates of global Pharmaceutical Intermediates market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 156800 million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Pharmaceutical Intermediates market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Intermediates market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Pharmaceutical Intermediates, covering the supply chain analysis, impact assessment to the Pharmaceutical Intermediates market size growth rate in several scenarios, and the measures to be undertaken by Pharmaceutical Intermediates companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
GMP
Non-GMP

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Antibiotics
Antipyretic Analgesics
Vitamins
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Lonza
Lianhetech
Catalent
Jubilant
Granules
Patheon
BASF
Ganesh
Porton
Chemcon
Yongtai
ABA Chem
Alpha
Jiujiujiu
Jiuzhou
Tianma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Pharmaceutical Intermediates consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Pharmaceutical Intermediates market by identifying its various subsegments.
Focuses on the key global Pharmaceutical Intermediates manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pharmaceutical Intermediates with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pharmaceutical Intermediates submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Pharmaceutical Intermediates?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Pharmaceutical Intermediates Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Intermediates Consumption 2015-2025
2.1.2 Pharmaceutical Intermediates Consumption CAGR by Region
2.2 Pharmaceutical Intermediates Segment by Type
2.2.1 GMP
2.2.2 Non-GMP
2.3 Pharmaceutical Intermediates Consumption by Type
2.3.1 Global Pharmaceutical Intermediates Consumption Market Share by Type (2015-2020)
2.3.2 Global Pharmaceutical Intermediates Revenue and Market Share by Type (2015-2020)
2.3.3 Global Pharmaceutical Intermediates Sale Price by Type (2015-2020)
2.4 Pharmaceutical Intermediates Segment by Application
2.4.1 Antibiotics
2.4.2 Antipyretic Analgesics
2.4.3 Vitamins
2.4.4 Others
2.5 Pharmaceutical Intermediates Consumption by Application
2.5.1 Global Pharmaceutical Intermediates Consumption Market Share by Type (2015-2020)
2.5.2 Global Pharmaceutical Intermediates Value and Market Share by Type (2015-2020)
2.5.3 Global Pharmaceutical Intermediates Sale Price by Type (2015-2020)

3 Global Pharmaceutical Intermediates by Company
3.1 Global Pharmaceutical Intermediates Sales Market Share by Company
3.1.1 Global Pharmaceutical Intermediates Sales by Company (2018-2020)
3.1.2 Global Pharmaceutical Intermediates Sales Market Share by Company (2018-2020)
3.2 Global Pharmaceutical Intermediates Revenue Market Share by Company
3.2.1 Global Pharmaceutical Intermediates Revenue by Company (2018-2020)
3.2.2 Global Pharmaceutical Intermediates Revenue Market Share by Company (2018-2020)
3.3 Global Pharmaceutical Intermediates Sale Price by Company
3.4 Global Pharmaceutical Intermediates Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Pharmaceutical Intermediates Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Pharmaceutical Intermediates Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Pharmaceutical Intermediates by Regions
4.1 Pharmaceutical Intermediates by Regions
4.2 Americas Pharmaceutical Intermediates Consumption Growth
4.3 APAC Pharmaceutical Intermediates Consumption Growth
4.4 Europe Pharmaceutical Intermediates Consumption Growth
4.5 Middle East & Africa Pharmaceutical Intermediates Consumption Growth

5 Americas
5.1 Americas Pharmaceutical Intermediates Consumption by Countries
5.1.1 Americas Pharmaceutical Intermediates Consumption by Countries (2015-2020)
5.1.2 Americas Pharmaceutical Intermediates Value by Countries (2015-2020)
5.2 Americas Pharmaceutical Intermediates Consumption by Type
5.3 Americas Pharmaceutical Intermediates Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Pharmaceutical Intermediates Consumption by Regions
6.1.1 APAC Pharmaceutical Intermediates Consumption by Regions (2015-2020)
6.1.2 APAC Pharmaceutical Intermediates Value by Regions (2015-2020)
6.2 APAC Pharmaceutical Intermediates Consumption by Type
6.3 APAC Pharmaceutical Intermediates Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Pharmaceutical Intermediates by Countries
7.1.1 Europe Pharmaceutical Intermediates Consumption by Countries (2015-2020)
7.1.2 Europe Pharmaceutical Intermediates Value by Countries (2015-2020)
7.2 Europe Pharmaceutical Intermediates Consumption by Type
7.3 Europe Pharmaceutical Intermediates Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Intermediates by Countries
8.1.1 Middle East & Africa Pharmaceutical Intermediates Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Pharmaceutical Intermediates Value by Countries (2015-2020)
8.2 Middle East & Africa Pharmaceutical Intermediates Consumption by Type
8.3 Middle East & Africa Pharmaceutical Intermediates Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Pharmaceutical Intermediates Distributors
10.3 Pharmaceutical Intermediates Customer

11 Global Pharmaceutical Intermediates Market Forecast
11.1 Global Pharmaceutical Intermediates Consumption Forecast (2021-2025)
11.2 Global Pharmaceutical Intermediates Forecast by Regions
11.2.1 Global Pharmaceutical Intermediates Forecast by Regions (2021-2025)
11.2.2 Global Pharmaceutical Intermediates Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Pharmaceutical Intermediates Forecast by Type
11.8 Global Pharmaceutical Intermediates Forecast by Application

12 Key Players Analysis
12.1 Lonza
12.1.1 Company Information
12.1.2 Pharmaceutical Intermediates Product Offered
12.1.3 Lonza Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Lonza Latest Developments
12.2 Lianhetech
12.2.1 Company Information
12.2.2 Pharmaceutical Intermediates Product Offered
12.2.3 Lianhetech Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Lianhetech Latest Developments
12.3 Catalent
12.3.1 Company Information
12.3.2 Pharmaceutical Intermediates Product Offered
12.3.3 Catalent Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Catalent Latest Developments
12.4 Jubilant
12.4.1 Company Information
12.4.2 Pharmaceutical Intermediates Product Offered
12.4.3 Jubilant Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Jubilant Latest Developments
12.5 Granules
12.5.1 Company Information
12.5.2 Pharmaceutical Intermediates Product Offered
12.5.3 Granules Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Granules Latest Developments
12.6 Patheon
12.6.1 Company Information
12.6.2 Pharmaceutical Intermediates Product Offered
12.6.3 Patheon Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Patheon Latest Developments
12.7 BASF
12.7.1 Company Information
12.7.2 Pharmaceutical Intermediates Product Offered
12.7.3 BASF Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 BASF Latest Developments
12.8 Ganesh
12.8.1 Company Information
12.8.2 Pharmaceutical Intermediates Product Offered
12.8.3 Ganesh Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Ganesh Latest Developments
12.9 Porton
12.9.1 Company Information
12.9.2 Pharmaceutical Intermediates Product Offered
12.9.3 Porton Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Porton Latest Developments
12.10 Chemcon
12.10.1 Company Information
12.10.2 Pharmaceutical Intermediates Product Offered
12.10.3 Chemcon Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Chemcon Latest Developments
12.11 Yongtai
12.11.1 Company Information
12.11.2 Pharmaceutical Intermediates Product Offered
12.11.3 Yongtai Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Yongtai Latest Developments
12.12 ABA Chem
12.12.1 Company Information
12.12.2 Pharmaceutical Intermediates Product Offered
12.12.3 ABA Chem Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 ABA Chem Latest Developments
12.13 Alpha
12.13.1 Company Information
12.13.2 Pharmaceutical Intermediates Product Offered
12.13.3 Alpha Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Alpha Latest Developments
12.14 Jiujiujiu
12.14.1 Company Information
12.14.2 Pharmaceutical Intermediates Product Offered
12.14.3 Jiujiujiu Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Jiujiujiu Latest Developments
12.15 Jiuzhou
12.15.1 Company Information
12.15.2 Pharmaceutical Intermediates Product Offered
12.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Jiuzhou Latest Developments
12.16 Tianma
12.16.1 Company Information
12.16.2 Pharmaceutical Intermediates Product Offered
12.16.3 Tianma Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Tianma Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Pharmaceutical Intermediates Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Pharmaceutical Intermediates Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Pharmaceutical Intermediates Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of GMP
Table 7. Major Players of Non-GMP
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Pharmaceutical Intermediates Consumption Market Share by Type (2015-2020)
Table 10. Global Pharmaceutical Intermediates Revenue by Type (2015-2020) ($ million)
Table 11. Global Pharmaceutical Intermediates Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Pharmaceutical Intermediates Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Pharmaceutical Intermediates Consumption Market Share by Application (2015-2020)
Table 15. Global Pharmaceutical Intermediates Value by Application (2015-2020)
Table 16. Global Pharmaceutical Intermediates Value Market Share by Application (2015-2020)
Table 17. Global Pharmaceutical Intermediates Sale Price by Application (2015-2020)
Table 18. Global Pharmaceutical Intermediates Sales by Company (2017-2019) (K MT)
Table 19. Global Pharmaceutical Intermediates Sales Market Share by Company (2017-2019)
Table 20. Global Pharmaceutical Intermediates Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Pharmaceutical Intermediates Revenue Market Share by Company (2017-2019)
Table 22. Global Pharmaceutical Intermediates Sale Price by Company (2017-2019)
Table 23. Global Pharmaceutical Intermediates Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Pharmaceutical Intermediates Products Offered
Table 25. Pharmaceutical Intermediates Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Pharmaceutical Intermediates Consumption by Regions 2015-2020 (K MT)
Table 27. Global Pharmaceutical Intermediates Consumption Market Share by Regions 2015-2020
Table 28. Global Pharmaceutical Intermediates Value by Regions 2015-2020 ($ Millions)
Table 29. Global Pharmaceutical Intermediates Value Market Share by Regions 2015-2020
Table 30. Americas Pharmaceutical Intermediates Consumption by Countries (2015-2020) (K MT)
Table 31. Americas Pharmaceutical Intermediates Consumption Market Share by Countries (2015-2020)
Table 32. Americas Pharmaceutical Intermediates Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Pharmaceutical Intermediates Value Market Share by Countries (2015-2020)
Table 34. Americas Pharmaceutical Intermediates Consumption by Type (2015-2020) (K MT)
Table 35. Americas Pharmaceutical Intermediates Consumption Market Share by Type (2015-2020)
Table 36. Americas Pharmaceutical Intermediates Consumption by Application (2015-2020) (K MT)
Table 37. Americas Pharmaceutical Intermediates Consumption Market Share by Application (2015-2020)
Table 38. APAC Pharmaceutical Intermediates Consumption by Countries (2015-2020) (K MT)
Table 39. APAC Pharmaceutical Intermediates Consumption Market Share by Countries (2015-2020)
Table 40. APAC Pharmaceutical Intermediates Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Pharmaceutical Intermediates Value Market Share by Regions (2015-2020)
Table 42. APAC Pharmaceutical Intermediates Consumption by Type (2015-2020) (K MT)
Table 43. APAC Pharmaceutical Intermediates Consumption Market Share by Type (2015-2020)
Table 44. APAC Pharmaceutical Intermediates Consumption by Application (2015-2020) (K MT)
Table 45. APAC Pharmaceutical Intermediates Consumption Market Share by Application (2015-2020)
Table 46. Europe Pharmaceutical Intermediates Consumption by Countries (2015-2020) (K MT)
Table 47. Europe Pharmaceutical Intermediates Consumption Market Share by Countries (2015-2020)
Table 48. Europe Pharmaceutical Intermediates Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Pharmaceutical Intermediates Value Market Share by Countries (2015-2020)
Table 50. Europe Pharmaceutical Intermediates Consumption by Type (2015-2020) (K MT)
Table 51. Europe Pharmaceutical Intermediates Consumption Market Share by Type (2015-2020)
Table 52. Europe Pharmaceutical Intermediates Consumption by Application (2015-2020) (K MT)
Table 53. Europe Pharmaceutical Intermediates Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Pharmaceutical Intermediates Consumption by Countries (2015-2020) (K MT)
Table 55. Middle East & Africa Pharmaceutical Intermediates Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Pharmaceutical Intermediates Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Pharmaceutical Intermediates Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Pharmaceutical Intermediates Consumption by Type (2015-2020) (K MT)
Table 59. Middle East & Africa Pharmaceutical Intermediates Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Pharmaceutical Intermediates Consumption by Application (2015-2020) (K MT)
Table 61. Middle East & Africa Pharmaceutical Intermediates Consumption Market Share by Application (2015-2020)
Table 62. Pharmaceutical Intermediates Distributors List
Table 63. Pharmaceutical Intermediates Customer List
Table 64. Global Pharmaceutical Intermediates Consumption Forecast by Countries (2021-2025) (K MT)
Table 65. Global Pharmaceutical Intermediates Consumption Market Forecast by Regions
Table 66. Global Pharmaceutical Intermediates Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Pharmaceutical Intermediates Value Market Share Forecast by Regions
Table 68. Global Pharmaceutical Intermediates Consumption Forecast by Type (2021-2025) (K MT)
Table 69. Global Pharmaceutical Intermediates Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Pharmaceutical Intermediates Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Pharmaceutical Intermediates Value Market Share Forecast by Type (2021-2025)
Table 72. Global Pharmaceutical Intermediates Consumption Forecast by Application (2021-2025) (K MT)
Table 73. Global Pharmaceutical Intermediates Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Pharmaceutical Intermediates Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Pharmaceutical Intermediates Value Market Share Forecast by Application (2021-2025)
Table 76. Lonza Product Offered
Table 77. Lonza Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 78. Lonza Main Business
Table 79. Lonza Latest Developments
Table 80. Lonza Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 81. Lianhetech Product Offered
Table 82. Lianhetech Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 83. Lianhetech Main Business
Table 84. Lianhetech Latest Developments
Table 85. Lianhetech Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 86. Catalent Product Offered
Table 87. Catalent Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 88. Catalent Main Business
Table 89. Catalent Latest Developments
Table 90. Catalent Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 91. Jubilant Product Offered
Table 92. Jubilant Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 93. Jubilant Main Business
Table 94. Jubilant Latest Developments
Table 95. Jubilant Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 96. Granules Product Offered
Table 97. Granules Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 98. Granules Main Business
Table 99. Granules Latest Developments
Table 100. Granules Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 101. Patheon Product Offered
Table 102. Patheon Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 103. Patheon Main Business
Table 104. Patheon Latest Developments
Table 105. Patheon Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 106. BASF Product Offered
Table 107. BASF Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 108. BASF Main Business
Table 109. BASF Latest Developments
Table 110. BASF Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 111. Ganesh Product Offered
Table 112. Ganesh Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 113. Ganesh Main Business
Table 114. Ganesh Latest Developments
Table 115. Ganesh Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 116. Porton Product Offered
Table 117. Porton Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 118. Porton Main Business
Table 119. Porton Latest Developments
Table 120. Porton Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 121. Chemcon Product Offered
Table 122. Chemcon Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 123. Chemcon Main Business
Table 124. Chemcon Latest Developments
Table 125. Chemcon Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 126. Yongtai Product Offered
Table 127. Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 128. Yongtai Main Business
Table 129. Yongtai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Yongtai Latest Developments
Table 131. ABA Chem Product Offered
Table 132. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 133. ABA Chem Main Business
Table 134. ABA Chem Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. ABA Chem Latest Developments
Table 136. Alpha Product Offered
Table 137. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 138. Alpha Main Business
Table 139. Alpha Latest Developments
Table 140. Alpha Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 141. Jiujiujiu Product Offered
Table 142. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 143. Jiujiujiu Main Business
Table 144. Jiujiujiu Latest Developments
Table 145. Jiujiujiu Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 146. Jiuzhou Product Offered
Table 147. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 148. Jiuzhou Main Business
Table 149. Jiuzhou Latest Developments
Table 150. Jiuzhou Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 151. Tianma Product Offered
Table 152. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 153. Tianma Main Business
Table 154. Tianma Latest Developments
Table 155. Tianma Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Pharmaceutical Intermediates
Figure 2. Pharmaceutical Intermediates Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Pharmaceutical Intermediates Consumption Growth Rate 2015-2025 (K MT)
Figure 5. Global Pharmaceutical Intermediates Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of GMP
Figure 7. Product Picture of Non-GMP
Figure 8. Global Pharmaceutical Intermediates Consumption Market Share by Type (2015-2020)
Figure 9. Global Pharmaceutical Intermediates Value Market Share by Type (2015-2020)
Figure 10. Pharmaceutical Intermediates Consumed in Antibiotics
Figure 11. Global Pharmaceutical Intermediates Market: Antibiotics (2015-2020) (K MT)
Figure 12. Global Pharmaceutical Intermediates Market: Antibiotics (2015-2020) ($ Millions)
Figure 13. Pharmaceutical Intermediates Consumed in Antipyretic Analgesics
Figure 14. Global Pharmaceutical Intermediates Market: Antipyretic Analgesics (2015-2020) (K MT)
Figure 15. Global Pharmaceutical Intermediates Market: Antipyretic Analgesics (2015-2020) ($ Millions)
Figure 16. Pharmaceutical Intermediates Consumed in Vitamins
Figure 17. Global Pharmaceutical Intermediates Market: Vitamins (2015-2020) (K MT)
Figure 18. Global Pharmaceutical Intermediates Market: Vitamins (2015-2020) ($ Millions)
Figure 19. Pharmaceutical Intermediates Consumed in Others
Figure 20. Global Pharmaceutical Intermediates Market: Others (2015-2020) (K MT)
Figure 21. Global Pharmaceutical Intermediates Market: Others (2015-2020) ($ Millions)
Figure 22. Global Pharmaceutical Intermediates Consumption Market Share by Application (2015-2020)
Figure 23. Global Pharmaceutical Intermediates Value Market Share by Application (2015-2020)
Figure 24. Global Pharmaceutical Intermediates Sales Market Share by Company in 2017
Figure 25. Global Pharmaceutical Intermediates Sales Market Share by Company in 2019
Figure 26. Global Pharmaceutical Intermediates Revenue Market Share by Company in 2017
Figure 27. Global Pharmaceutical Intermediates Revenue Market Share by Company in 2019
Figure 28. Global Pharmaceutical Intermediates Sale Price by Company in 2019
Figure 29. Global Pharmaceutical Intermediates Consumption Market Share by Regions 2015-2020
Figure 30. Global Pharmaceutical Intermediates Value Market Share by Regions 2015-2020
Figure 31. Americas Pharmaceutical Intermediates Consumption 2015-2020 (K MT)
Figure 32. Americas Pharmaceutical Intermediates Value 2015-2020 ($ Millions)
Figure 33. APAC Pharmaceutical Intermediates Consumption 2015-2020 (K MT)
Figure 34. APAC Pharmaceutical Intermediates Value 2015-2020 ($ Millions)
Figure 35. Europe Pharmaceutical Intermediates Consumption 2015-2020 (K MT)
Figure 36. Europe Pharmaceutical Intermediates Value 2015-2020 ($ Millions)
Figure 37. Middle East & Africa Pharmaceutical Intermediates Consumption 2015-2020 (K MT)
Figure 38. Middle East & Africa Pharmaceutical Intermediates Value 2015-2020 ($ Millions)
Figure 39. Americas Pharmaceutical Intermediates Consumption Market Share by Countries in 2019
Figure 40. Americas Pharmaceutical Intermediates Value Market Share by Countries in 2019
Figure 41. Americas Pharmaceutical Intermediates Consumption Market Share by Type in 2019
Figure 42. Americas Pharmaceutical Intermediates Consumption Market Share by Application in 2019
Figure 43. United States Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 44. United States Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 45. Canada Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 46. Canada Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 47. Mexico Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 48. Mexico Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 49. APAC Pharmaceutical Intermediates Consumption Market Share by Countries in 2019
Figure 50. APAC Pharmaceutical Intermediates Value Market Share by Regions in 2019
Figure 51. APAC Pharmaceutical Intermediates Consumption Market Share by Type in 2019
Figure 52. APAC Pharmaceutical Intermediates Consumption Market Share by Application in 2019
Figure 53. China Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 54. China Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 55. Japan Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 56. Japan Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 57. Korea Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 58. Korea Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 59. Southeast Asia Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 60. Southeast Asia Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 61. India Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 62. India Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 63. Australia Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 64. Australia Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 65. Europe Pharmaceutical Intermediates Consumption Market Share by Countries in 2019
Figure 66. Europe Pharmaceutical Intermediates Value Market Share by Countries in 2019
Figure 67. Europe Pharmaceutical Intermediates Consumption Market Share by Type in 2019
Figure 68. Europe Pharmaceutical Intermediates Consumption Market Share by Application in 2019
Figure 69. Germany Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 70. Germany Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 71. France Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 72. France Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 73. UK Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 74. UK Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 75. Italy Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 76. Italy Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 77. Russia Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 78. Russia Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 79. Middle East & Africa Pharmaceutical Intermediates Consumption Market Share by Countries in 2019
Figure 80. Middle East & Africa Pharmaceutical Intermediates Value Market Share by Countries in 2019
Figure 81. Middle East & Africa Pharmaceutical Intermediates Consumption Market Share by Type in 2019
Figure 82. Middle East & Africa Pharmaceutical Intermediates Consumption Market Share by Application in 2019
Figure 83. Egypt Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 84. Egypt Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 85. South Africa Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 86. South Africa Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 87. Israel Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 88. Israel Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 89. Turkey Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 90. Turkey Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 91. GCC Countries Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)
Figure 92. GCC Countries Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)
Figure 93. Global Pharmaceutical Intermediates Consumption Growth Rate Forecast (2021-2025) (K MT)
Figure 94. Global Pharmaceutical Intermediates Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 95. Americas Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 96. Americas Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 97. APAC Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 98. APAC Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 99. Europe Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 100. Europe Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 101. Middle East & Africa Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 102. Middle East & Africa Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 103. United States Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 104. United States Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 105. Canada Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 106. Canada Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 107. Mexico Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 108. Mexico Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 109. Brazil Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 110. Brazil Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 111. China Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 112. China Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 113. Japan Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 114. Japan Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 115. Korea Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 116. Korea Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 117. Southeast Asia Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 118. Southeast Asia Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 119. India Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 120. India Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 121. Australia Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 122. Australia Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 123. Germany Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 124. Germany Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 125. France Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 126. France Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 127. UK Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 128. UK Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 129. Italy Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 130. Italy Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 131. Russia Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 132. Russia Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 133. Spain Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 134. Spain Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 135. Egypt Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 136. Egypt Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 137. South Africa Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 138. South Africa Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 139. Israel Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 140. Israel Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 141. Turkey Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 142. Turkey Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 143. GCC Countries Pharmaceutical Intermediates Consumption 2021-2025 (K MT)
Figure 144. GCC Countries Pharmaceutical Intermediates Value 2021-2025 ($ Millions)
Figure 145. Lonza Pharmaceutical Intermediates Market Share (2018-2020)
Figure 146. Lianhetech Pharmaceutical Intermediates Market Share (2018-2020)
Figure 147. Catalent Pharmaceutical Intermediates Market Share (2018-2020)
Figure 148. Jubilant Pharmaceutical Intermediates Market Share (2018-2020)
Figure 149. Granules Pharmaceutical Intermediates Market Share (2018-2020)
Figure 150. Patheon Pharmaceutical Intermediates Market Share (2018-2020)
Figure 151. BASF Pharmaceutical Intermediates Market Share (2018-2020)
Figure 152. Ganesh Pharmaceutical Intermediates Market Share (2018-2020)
Figure 153. Porton Pharmaceutical Intermediates Market Share (2018-2020)
Figure 154. Chemcon Pharmaceutical Intermediates Market Share (2018-2020)
Figure 155. Yongtai Pharmaceutical Intermediates Market Share (2018-2020)
Figure 156. ABA Chem Pharmaceutical Intermediates Market Share (2018-2020)
Figure 157. Alpha Pharmaceutical Intermediates Market Share (2018-2020)
Figure 158. Jiujiujiu Pharmaceutical Intermediates Market Share (2018-2020)
Figure 159. Jiuzhou Pharmaceutical Intermediates Market Share (2018-2020)
Figure 160. Tianma Pharmaceutical Intermediates Market Share (2018-2020)

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3660
USD $5490
USD $7320
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.